NDC 50419-332 – Ambelvist

Gadoquatrane 257.9 mg/mL · Injection · Intravenous

Human Prescription Drug

Product NDC50419-332

Product details

Brand name
Ambelvist
Generic name
Gadoquatrane
Labeler
Bayer HealthCare Pharmaceuticals Inc.
Dosage form
Injection
Route
Intravenous
Marketing category
NDA · NDA219627
Marketed since
June 12, 2026
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Ambelvist →

Package NDC codes (1)

Package NDCDescriptionSince
50419-332-115 SYRINGE in 1 CARTON (50419-332-11) / 15 mL in 1 SYRINGE (50419-332-01)Jun 12, 2026

Other Ambelvist products